Curiosis

494120 · KOSDAQ · ₩494120 · 큐리오시스

₩8,710▲ ₩520 (6.35%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −80.21%
Market cap
₩133B
Enterprise value
₩116B
P/E
—
P/B
5.4×
Dividend yield
0.0%
ROE
−31.5%
Net margin
−92.1%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−81.9% from the high

₩6,900Today: ₩8,110 – ₩8,770₩48,218

Returns

  • 1W+7.8%
  • 1M+6.6%
  • 3M−6.0%
  • 6M−68.6%
  • YTD−64.5%
  • 1Y—
Volume today
127,191
1.3× the 20-day average
Traded today
₩1.1B
Listed shares
15,259,764
EPS (12 months)
−₩510
Earnings yield −5.9%

Why is it moving?

+6.4% on Oct 27, 2026.

  • • Foreign investors bought a net ₩31M that day

We found no news, filing or broker report explaining it yet. Moves without news happen; it may come later.

Possible reasons, not certainties. Not financial advice.

Signals

49Normal
  • BuzzNormalBuzz 49 of 100 (50 is a normal day for this stock).
  • MomentumFlat8.9% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Curiosis stock overview

Curiosis (큐리오시스, KRX: 494120) is listed on KOSDAQ, in the Medical & precision devices sector. The company, founded in January 2015, is a bio-materials and parts firm supplying lab automation solutions. Its shares closed at ₩8,710 on Oct 27, 2026, up 6.35% on the day, giving it a market value of ₩133B.

Key facts

Market cap
₩133B
Sector
Medical & precision devices
Latest price change
+6.35%
As of
Oct 27, 2026
Main business
The company, founded in January 2015, is a bio-materials and parts firm supplying lab automation solutions.

Quick answers about Curiosis

What does Curiosis do?
The company, founded in January 2015, is a bio-materials and parts firm supplying lab automation solutions. It develops and manufactures its own life science research instruments, lab automation products and medical devices at its in-house factory in Yongin, Gyeonggi Province, and sells them to customers in life sciences research, diagnostics, pharmaceuticals and biotechnology. Its main product lines include the Celloger live-cell imaging system, the Cellpuri cell concentration and blood component separation system, the MSP digital pathology system and the CPX colony picking system.
What is the market cap of Curiosis?
The market capitalisation of Curiosis was ₩133B at the close on Oct 27, 2026.
Who are the largest shareholders of Curiosis?
According to the latest official filings, the largest reported holders are Yoon Ho-young (12.38%, as of Aug 20, 2026); Midas Asset Management (5.00%, as of Jul 7, 2026); STIC Ventures (4.42%, as of Nov 20, 2025).
When is the next earnings report from Curiosis?
Korean companies rarely announce results dates in advance. Based on when Curiosis filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Does the National Pension Service own Curiosis?
Yes. The National Pension Service held 2.54% of Curiosis shares as of Dec 31, 2025.

Company profile

The company, founded in January 2015, is a bio-materials and parts firm supplying lab automation solutions. It develops and manufactures its own life science research instruments, lab automation products and medical devices at its in-house factory in Yongin, Gyeonggi Province, and sells them to customers in life sciences research, diagnostics, pharmaceuticals and biotechnology. Its main product lines include the Celloger live-cell imaging system, the Cellpuri cell concentration and blood component separation system, the MSP digital pathology system and the CPX colony picking system.

Written by AI from the company's latest annual report.

Korean name
큐리오시스
CEO
윤호영
Founded
Jan 2015
Listed
Nov 2025
Listed shares
15,259,764
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Curiosis / 큐리오시스 / 494120 / KRX:494120

Source: KRX statistical information